Skip to main content
Log in

Gut hormones and gastrointestinal motility in children with cystic fibrosis

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Intestinal dysmotility may be an important factor contributing to various gastrointestinal complications associated with cystic fibrosis. Motilin, enteroglucagon, neurotensin, and peptide YY may each play a role as endocrine hormones influencing gastrointestinal motor activity. Fasting children with cystic fibrosis (N=8) and controls (N=18) received a liquid nutrient test meal (fat 4 g/100 ml, protein 4 g/100 ml, carbohydrate 20 g/100 ml, 125 kcal/100 ml; 200 ml/m2) containing lactulose (5 g/100 ml), and the plasma concentrations of these peptides were studied. Mouth-to-cecum transit time was simultaneously studied using the breath H2 technique. Fasting levels of peptide YY and the postprandial response of all four peptides were significantly increased in those with cystic fibrosis. In repeat studies on those with cystic fibrosis after a period of altered pancreatic enzyme supplementation, no significant changes in peptide concentrations were observed. A rise in breath H2 permitting estimation of mouth-to-cecum transit time was noted in 17 control subjects (70–220 min, median 140). In contrast, a rise occurred in only two with cystic fibrosis after low-dose enzyme (70 and 180 min), and four after high-dose enzyme replacement (120–230 min, median 155). Altered gut hormone secretion may play a role in the pathophysiology of intestinal dysmotility in patients with cystic fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Corey M, Gaskin K, Durie P, Levison H, Forstner G: Improved prognosis in CF patients with normal fat absorption. J Pediatr Gastroenterol Nutr 3(suppl 1):S99-S105, 1984

    Google Scholar 

  2. Bali A, Stableforth D, Asquith P: Evidence for bacterial contamination of the small intestine in adults with cystic fibrosis.In: Cystic Fibrosis: Horizons. Proceedings of the 9th International Cystic Fibrosis Congress, Brighton, England. D Lawson (ed). Chichester: Wiley Medical Publication, 1984, p. 323 (abstract)

    Google Scholar 

  3. Vantrappen G, Janssens J, Hellemans J, Ghoos Y: The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 59:1158–1166, 1977

    Google Scholar 

  4. Park RW, Grand RJ: Gastrointestinal manifestations of cystic fibrosis: A review. Gastroenterology 81:1143–1161, 1981

    Google Scholar 

  5. Ingelfinger FJ, Moss RE: The motility of the small intestine in sprue. J Clin Invest 22:345–352, 1943

    Google Scholar 

  6. Pirk F: Changes in the motility of the small intestine in digestive disorders. Gut 8:486–490, 1967

    Google Scholar 

  7. Cook GC: Delayed small intestinal transit in tropical malabsorption. Br Med J 2:238–240, 1978

    Google Scholar 

  8. Spiller RC, Lee YC, Edge C, Ralphs DNL, Bloom SR, Stewart JS, Silk DBAS: Functional significance of the ileal brake in coeliac disease. Gut 25:545, 1984

    Google Scholar 

  9. Bali A, Stableforth DE, Asquith P: Prolonged small-intestinal transit time in cystic fibrosis. Br Med J 287:1011–1013, 1983

    Google Scholar 

  10. Bond JH, Levitt MD: Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med 85:546–555, 1975

    Google Scholar 

  11. Perman JA, Barr RG, Watkins JB: Sucrose malabsorption in children; non-invasive diagnosis by interval breath hydrogen determination. J Pediatr 93:17–22, 1978

    Google Scholar 

  12. Bloom SR, Long RG: Radioimmunoassay of Gut Regulatory Peptides. London, WB Saunders, 1982

    Google Scholar 

  13. Adrian TE, Ferri G-L, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR: Human distribution and release of a putative new gut hormone, peptide YY (PYY). Gastroenterology 89:1070–1077, 1985

    Google Scholar 

  14. Hyman PE: Absent postprandial duodenal motility in a child with cystic fibrosis. Correction of the symptoms and manometric abnormality with cisapride. Gastroenterology 90:1274–1279, 1986

    Google Scholar 

  15. DiMagno EP, Malagelada J-R, Go VLW, Moertel CG: Fate of orally ingested enzymes in pancreatic insufficiency: Comparison of two dosage schedules. N Engl J Med 296:1318–1322, 1977

    Google Scholar 

  16. Neijens HH, Sinaasappel M (eds): Gastrointestinal and Nutritional Aspects in CF and its Relation with the Respiratory System. Proceedings of a Workshop held in the Sophia Children's Hospital, Erasmus University, Rotterdam, The Netherlands. Acta Paediatr Scand 317(suppl):1–47, 1985

  17. Besterman HS, Cook GC, Sarson DL, Christofides ND, Bryant MG, Gregor M, Bloom SR: Gut hormones in tropical malabsorption. Br Med J 2:1252–1255, 1979

    Google Scholar 

  18. Hernanz A, Polanco Isabel, Codoceo R, Lama R, Vazquez C: Gastrointestinal peptide profile in children with celiac disease. J Pediatr Gastroenterol Nutr 6:341–345, 1987

    Google Scholar 

  19. Allen JM, Penketh ARL, Adrian TE, Lee YC, Sarson DL, Hodson ME, Batten JC, Bloom SR: Adult cystic fibrosis: postprandial response of gut regulatory peptides. Gastroenterology 85:1379–1383, 1983

    Google Scholar 

  20. Adrian TE, McKiernan J, Johnstone DI, Hiller EJ, Vyas H, Sarson DL, Bloom SR: Hormonal abnormalities of the pancreas and gut in cystis fibrosis. Gastroenterology 79:460–465, 1980

    Google Scholar 

  21. Adrian TE, Savage AP, Barcarese-Hamilton AJ, Wolfe K, Besterman HS, Bloom SR: Peptide YY abnormalities in gastrointestinal disease. Gastroenterology 90:379–384, 1986

    Google Scholar 

  22. Sjolund K, Ekman R: Increased plasma levels of peptide YY in coeliac disease. Scand J Gastroenterol 23:297–300, 1988

    Google Scholar 

  23. Ebert R, Creutzfeldt W: Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia 19:198–204, 1980

    Google Scholar 

  24. Vantrappen G, Peeters TL: Motilin.In Handbook of Physiology. The Gastrointestinal system. Section 6, Vol II. SG Schultz, GM Makhluf, BB Rauner (eds). Bethesda, Maryland, American Physiological Society, 1989, p 545–558

    Google Scholar 

  25. Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ, Silk DB: The ileal brake—inhibition of jejunal motility after ileal fat perfusion in man. Gut 25:365–374, 1984

    Google Scholar 

  26. Bloom SR: An enteroglucagon tumour. Gut 13:520–523, 1972

    Google Scholar 

  27. Blackburn M, Fletcher DR, Bloom SR, Chirstophides ND, Long RG, Fitzpatrick ML, Baron JH: Effect of neurotensin on gastric function in man. Lancet 1:987–989, 1980

    Google Scholar 

  28. Thor K, Rosell S, Rokaeus A, Kager L: [Gln4]-Neurotensin changes the motility pattern of the duodenum and proximal jejunum from a fasting type to a fed type. Gastroenterology 83:569–574, 1982

    Google Scholar 

  29. Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR: Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 28:166–170, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murphy, M.S., Brunetto, A.L., Pearson, A.D.J. et al. Gut hormones and gastrointestinal motility in children with cystic fibrosis. Digest Dis Sci 37, 187–192 (1992). https://doi.org/10.1007/BF01308170

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01308170

Key Words

Navigation